These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
809 related articles for article (PubMed ID: 24878287)
1. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma. Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287 [TBL] [Abstract][Full Text] [Related]
2. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma. Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753 [TBL] [Abstract][Full Text] [Related]
3. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade. Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis. Patil SS; Gokulnath P; Bashir M; Shwetha SD; Jaiswal J; Shastry AH; Arimappamagan A; Santosh V; Kondaiah P Neuro Oncol; 2016 Nov; 18(11):1487-1497. PubMed ID: 27044294 [TBL] [Abstract][Full Text] [Related]
6. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. Liang Y; Bollen AW; Aldape KD; Gupta N BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952 [TBL] [Abstract][Full Text] [Related]
7. Mediation of multiple pathways regulating cell proliferation, migration, and apoptosis in the human malignant glioma cell line U87MG via unphosphorylated STAT1: laboratory investigation. Ju H; Li X; Li H; Wang X; Wang H; Li Y; Dou C; Zhao G J Neurosurg; 2013 Jun; 118(6):1239-47. PubMed ID: 23600941 [TBL] [Abstract][Full Text] [Related]
8. ACTC1 as an invasion and prognosis marker in glioma. Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897 [TBL] [Abstract][Full Text] [Related]
9. High CHI3L1 expression is associated with glioma patient survival. Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858 [TBL] [Abstract][Full Text] [Related]
10. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients. Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566 [TBL] [Abstract][Full Text] [Related]
11. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma. Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279 [TBL] [Abstract][Full Text] [Related]
13. Effects of IGFBP-3 and GalNAc-T14 on proliferation and cell cycle of glioblastoma cells and its mechanism. Yang J; Hu Y; Wu J; Kong S J Pharm Pharmacol; 2020 Feb; 72(2):218-226. PubMed ID: 31713889 [TBL] [Abstract][Full Text] [Related]
14. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance. Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients. Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418 [TBL] [Abstract][Full Text] [Related]
16. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas. Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062 [TBL] [Abstract][Full Text] [Related]
18. Investigation of serum levels and tissue expression of two genes IGFBP-2 and IGFBP-3 act as potential biomarker for predicting the progression and survival in patients with glioblastoma multiforme. Abdolhoseinpour H; Mehrabi F; Shahraki K; Khoshnood RJ; Masoumi B; Yahaghi E; Goudarzi PK J Neurol Sci; 2016 Jul; 366():202-206. PubMed ID: 27288807 [TBL] [Abstract][Full Text] [Related]
19. Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma. Shi Y; Chen C; Zhang X; Liu Q; Xu JL; Zhang HR; Yao XH; Jiang T; He ZC; Ren Y; Cui W; Xu C; Liu L; Cui YH; Yu SZ; Ping YF; Bian XW Clin Cancer Res; 2014 Apr; 20(7):1803-13. PubMed ID: 24523440 [TBL] [Abstract][Full Text] [Related]
20. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro. Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]